GlassScriptPhysician profile
Amy K Hicks
NPI 1841506730
$4,044.82
in general payments reported to CMS, 2019-2025
38 companies · $925 in 2025
The $925 reported for 2025 was more than what 85% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $263 · 2022: $902 · 2023: $975 · 2024: $980 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,795 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,794.76 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $989.38 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $401.38 | 2022-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $329.66 | 2022-2024 | |
| Corium, LLC | $236.05 | 2023-2025 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $213.80 | 2022 | |
| Exact Sciences Corporation | $201.80 | 2023-2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $141.44 | 2023-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Inari Medical, INC. | $133.22 | 2023-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Sumitomo Pharma America, INC. | $129.92 | 2023-2024 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $120.52 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.51 | 2021-2025 | Jardiance |
| Pfizer INC. | $89.33 | 2022-2025 | |
| Lilly USA, LLC | $87.07 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Astellas Pharma US INC | $84.99 | 2023 | |
| Antares Pharma, INC. | $71.56 | 2022-2024 | Xyosted |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.